A significant development is underway in the litigation surrounding the Cartiva synthetic cartilage implant, one that could reshape the legal landscape for injured patients nationwide. On October 31, 2025, several plaintiffs nationwide with lawsuits against Cartiva filed a motion in federal court seeking consolidation of all Cartiva-related lawsuits in a single federal court under a Multidistrict Litigation (MDL).
On November 28, 2025, the personal injury lawyers at Pullano & Siporin, who represent many Cartiva victims, filed a motion in support of consolidating all of the Cartiva-related lawsuits. The Motion in Support also requests that the MDL be transferred to the Northern District of Illinois for litigation, because Pullano & Siporin represents four plaintiffs with lawsuits against Cartiva currently pending in the Northern District, which is located in Chicago, Illinois.
For the thousands of individuals who received the Cartiva implant only to suffer complications, this request marks a significant and potentially beneficial turning point. The creation of an MDL can dramatically streamline case progress, reduce inconsistencies across courts, and strengthen plaintiffs’ ability to pursue justice with the help of experienced personal injury lawyers in Chicago.
What Is an MDL and How Does it Work?
Multidistrict Litigation is a federal procedure used to consolidate a large number of lawsuits involving similar injuries, allegations, and the same defective product. While MDLs are sometimes confused with class actions, the two are not the same.
Each plaintiff in an MDL maintains an individual lawsuit and retains control over their own claim. The cases are consolidated before a single federal judge to streamline pretrial proceedings.
Once formed, an MDL handles discovery, expert witness matters, evidence collection, and key legal questions. For plaintiffs, this process can lead to faster progress, greater leverage in negotiations, and a more precise litigation roadmap, guided by Chicago personal injury attorneys at Pullano & Siporin, who are familiar with medical device and product liability claims.
An MDL is typically created when:
- A large number of plaintiffs have filed similar lawsuits
- The cases share a common question of fact
- Consolidation will prevent duplicative discovery
- Centralized management will promote consistent rulings
Why Plaintiffs Are Seeking MDL Consolidation for Cartiva Lawsuits
The Cartiva synthetic cartilage implant was recognized as a breakthrough alternative to joint fusion for patients with arthritis and big toe joint pain. Instead of permanently fusing bones, the implant promised pain relief while preserving mobility, an appealing option for many patients.
However, increasing reports have surfaced of serious complications, including:
- Implant loosening or sinking
- Progressive joint pain
- Inflammation and stiffness
- Loss of mobility
- Device malfunction
- The need for revision or fusion surgery
Many patients required more invasive procedures than they originally hoped to avoid. These complications are at the heart of the growing lawsuits filed nationwide.
Attorneys at Pullano & Siporin represent plaintiffs and recognize that courts repeatedly address questions about the device’s safety, the adequacy of warnings, and whether the manufacturer misrepresented its performance and durability. These overlapping issues make the Cartiva litigation a strong candidate for consolidation.
The motion filed on October 31 argues that centralizing these cases will:
- Promote judicial efficiency
- Prevent conflicting rulings from different courts
- Reduce repeated and unnecessary discovery burdens
- Accelerate progress toward resolution
For plaintiffs, an MDL could be a powerful tool for achieving fair and consistent outcomes. Our Chicago injury attorneys have experience in product liability and personal injury cases and closely monitor developments in these areas.
How the MDL Request May Influence New Cartiva Filings
The filing of the MDL request is expected to influence the number of new lawsuits as well. When an MDL is requested, especially in medical device litigation, plaintiffs often file their cases directly in federal court to be included in the consolidation proceedings once the MDL is approved.
More federal filings can strengthen the argument that:
- The litigation is national in scope
- Numerous plaintiffs share common injuries
- Centralization is in the best interest of efficiency and fairness
For individuals who believe their Cartiva implant failed, filing sooner rather than later can preserve their legal rights and ensure their case is included in the MDL. Personal injury lawyers at Pullano & Siporin can help determine eligibility and guide patients through this process.
What an Approved MDL Could Mean for Cartiva Patients
If the JPML grants the MDL request, the consolidation could offer several meaningful benefits for injured patients:
- Streamline Litigation — All cases would share coordinated discovery, reducing delays and eliminating repetitive work across dozens of courtrooms.
- Consistent Rulings — A single judge overseeing the pretrial process helps prevent conflicting or contradictory decisions from different jurisdictions
- Strong Expert Testimony — Manufacturers often take litigation more seriously when cases are centralized and moving forward in a unified manner. MDLs can increase the likelihood of global settlement discussions.
- Increased Settlement Potential — Manufacturers often take litigation more seriously when cases are centralized and moving forward in a unified manner. MDLs can increase the likelihood of global settlement discussions.
- Empowered Plaintiffs — Rather than facing a large manufacturer alone, plaintiffs benefit from shared resources, coordinated legal strategies, and a more balanced playing field. This is why our Chicago personal injury attorneys’ experience in product liability cases underscores the importance of early action.
Pullano & Siporin — Leading the Fight for Cartiva Patients
As the push for a Cartiva Multidistrict Litigation moves forward, plaintiffs have an important opportunity to level the playing field against a major medical device manufacturer. The motion filed on October 31, 2025, signals a turning point, one that could streamline litigation, strengthen claims, and accelerate justice for those harmed by the Cartiva implant. But to take advantage of what an MDL offers, patients need experienced, strategic legal representation.
At Pullano & Siporin, our attorneys are not only deeply involved in this litigation—we are helping lead it. By filing the motion in support of consolidation, our firm is actively shaping the structure of the Cartiva cases nationwide. This gives our clients a meaningful advantage: we understand the complexities of the medical device, the legal issues at stake, and the strategy required to build a compelling case within an MDL.
Our team has decades of experience handling product liability and defective medical device lawsuits, including complex cases involving federal courts, expert testimony, and large-scale discovery. We know how to investigate device failures, work with elite medical experts, and pursue compensation for medical expenses, lost income, pain and suffering, and the long-term consequences of revision surgeries.
Most importantly, we understand what Cartiva patients are going through. Your injury is not just a case. It disrupts your health, mobility, and daily life. Our attorneys are committed to walking you through every stage of the litigation, ensuring you are informed, protected, and empowered throughout the process. If you believe your Cartiva implant has failed, now is the time to act.
Contact us today to discuss your legal options, preserve your rights, and position your case for the strongest possible outcome in what may soon become one of the most significant medical device MDLs in the country.
